Gluvoiz PM 2mg/500mg/15mg Tablet SR
Marketer
Ellanjey Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gluvoiz PM 2mg/500mg/15mg Tablet SR
Diabex Trio 2mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It improves insulin effectiveness, consequently reducing blood sugar. Always follow your physician's prescribed dosage and schedule for Diabex Trio 2mg/500mg/15mg Extended-Release Tablets. Take with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or breastfeeding individuals should seek medical counsel before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption to mitigate potential side effect risks.
Primary Ingredients of Gluvoiz PM 2mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish to be rewritten.
Uses of Gluvoiz PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gluvoiz PM 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gluvoiz PM 2mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of Gluvoiz PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gluvoiz PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gluvoiz PM 2mg/500mg/15mg SR Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.
How Gluvoiz PM 2mg/500mg/15mg Tablet SR works:
Gluvoiz PM 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gluvoiz PM 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gluvoiz PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Gluvoiz PM 2mg/500mg/15mg tablet likely poses a risk during lactation. Available human data indicate potential drug transfer to breast milk, with a possibility of infant harm.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gluvoiz PM 2mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gluvoiz PM 2mg/500mg/15mg SR tablets cautiously, as dose modification may be necessary. Consult a physician before use. Gluvoiz PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gluvoiz PM 2mg/500mg/15mg Tablet SR :
Should you forget to take your Gluvoiz PM 2mg/500mg/15mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Gluvoiz PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently